???global.info.a_carregar???
Maria Mota completed her BSc in Biology and an MSc in Immunology from the University of Porto, her PhD in Parasitology at the University College London/NIMR and a post-doc at NYU. Since 2002 Maria Mota has been a group leader, first at Instituto Gulbenkian de Ciência (IGC) and then at Instituto de Medicina Molecular (iMM). As an independent researcher Maria Mota focused on studying both the liver and the blood stages of infection by the Plasmodium parasite. Her team¿s overall goal has been towards the elucidation of the most fundamental and conceptually innovative questions of Host-Plasmodium interactions leading to groundbreaking discoveries. By showing that Plasmodium activates a type I IFN response in the liver (Nature Medicine, 2014) the Mota Lab has challenged the widespread assumption that Plasmodium can infect and replicate inside hepatocytes undetected. Her work also demonstrates that active interactions with the host cellular machinery are required during Plasmodium liver stage to prevent clearance. Examples are two proteins that operate on ensuring parasite survival by blocking infected cells autophagy (Nature Microbiology, 2018) and through interaction with host cell actin to elute host cytosolic defenses (iScience, 2022). With recent work the team further enriched our understanding on liver stage infection by providing a comprehensive single-cell gene profiling of hepatocytes and parasites in infected livers over time (Nature, 2022). Furthermore, Maria Mota’s team revealed that nutrient availability and dietary habits strongly impact the establishment and course of a malaria infection by interfering with both host and parasite pathways during different stages of infection (Nature, 2017; Nature Microbiology, 2017; Communications Biology, 2023). Recent data from the Mota Lab reveals the intricate nature of Host-Plasmodium interactions by showing that the liver stage and the blood stage interact towards pathology and disease severity (Immunity, 2023). Moreover, Maria Mota´s team identified a third party determining disease: host microbiota (Nature Communications, 2022). In 2012 Maria Mota received a 5-year Starting/Consoliadtor Grant from the European Research Council (ERC), as well as a 3-year Excellence Grant from FCT. In 2018, Maria Mota was awarded a laCaixa Foundation Health Research Grant. Recently, in 2023, the innovative nature of her research lead to the successful securing of new funding from the ERC with a 5-year Advanced Grant, and from the laCaixa Foundation with another 3-year Health Research Grant. At the institutional level, Maria Mota lead the successful securing of EU-funded projects such as TwinnToInfect (H2020-TWINN-2015) and EXCELLtoINNOV (H2020- Establishing ERA Chairs) to provide IMM with the needed means to achieve international excellence in the immunity and infection area and iMM-CARE (HORIZON-WIDERA-2022- Teaming for Excellence) towards establishing a new centre of excellence for clinical and translational research. Maria Mota has published more than 140 papers cited more than 7000 times (h-index = 49). She has supervised 15 PhD students (concluded) and more than 18 post-doctoral fellows (current and concluded). Her scientific merit was recognized internationally and won several prizes and awards such as: EMBO member by the European Molecular Biology Organization in 2016 and in 2018 the Sanofi Institut Pasteur Mid-Career Award. Nationally, in 2017 Maria Mota was awarded the Pfizer Prize in Basic Research and in 2013 she was awarded the Pessoa Award, a prestigious national award. Since April 2014 Maria Mota is the Executive Director of iMM. Under her leadership, iMM has significantly enriched its critical mass and became a dynamic structure based on a vibrant faculty with an outstanding research portfolio. iMM is now merging with IGC. A new Foundation has been created – Gulbenkian Institute for Molecular Medicine (GIMM) and Maria Mota was recently elected the President and CEO of GIMM.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Maria Manuel Dias da Mota

Nomes de citação

  • Mota, Maria M.
  • Mota, MM
  • Maria Manuel Mota

Identificadores de autor

Ciência ID
4217-0969-297E
ORCID iD
0000-0002-2858-1041

Endereços de correio eletrónico

  • maria.mota@gimm.pt (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Ciências da Saúde - Parasitologia
  • Ciências Naturais - Ciências Biológicas - Microbiologia
  • Ciências Naturais - Ciências Biológicas - Biologia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Português (Idioma materno)
Formação
Grau Classificação
2019/07/17
Concluído
 Biomedical Sciences (Título de Agregado)
Especialização em Microbiology and Parasitology
Universidade de Lisboa Faculdade de Medicina, Portugal
 Aprovado
1999
Concluído
 Molecular Parasitology (Doutoramento)
National Institute for Medical Research, University College London, Reino Unido
"Sequestration and the infected-erythrocyte surface in Plasmodium chabaudi malaria infection" (TESE/DISSERTAÇÃO)
 -
1995
Concluído
 Imunologia (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Studies on Plasma Produced during resolution of parasitemia in rodent malaria" (TESE/DISSERTAÇÃO)
 -
1992
Concluído
 Licenciatura em Biologia (Licenciatura)
Universidade do Porto Faculdade de Ciências, Portugal
"n/a" (TESE/DISSERTAÇÃO)
 -
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2024/10/01 - Atual Investigador Coordenador (carreira) (Investigação) Gulbenkian Institute for Molecular Medicine, Portugal
2005/04/01 - 2024/09/30 Investigador Coordenador (carreira) (Investigação) Instituto de Medicina Molecular, Portugal
Instituto de Medicina Molecular, Portugal
2002/01/01 - 2004/12/31 Investigador principal (carreira) (Investigação) Instituto Gulbenkian de Ciência, Portugal
1999/11/01 - 2001/01/31 Pós-doutorado (Investigação) NewYork-Presbyterian/Columbia University Medical Center, Estados Unidos

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2014 - Atual Professor Associado Convidado (Docente Universitário) Universidade de Lisboa, Portugal
2011/06/01 - 2019/12/31 Professor Visitante (Docente Universitário) Harvard University T H Chan School of Public Health, Estados Unidos
Harvard University T H Chan School of Public Health, Estados Unidos
2013 - 2014 Professor Auxiliar (Docente Universitário) Universidade de Lisboa Faculdade de Medicina, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2024/10/01 - Atual Chief Executive Officer Gulbenkian Institute for Molecular Medicine, Portugal
2014/04/01 - 2024/09/30 Executive Director Instituto de Medicina Molecular, Portugal
Instituto de Medicina Molecular, Portugal
Projetos

Bolsa

Designação Financiadores
2023/05/01 - 2029/04/30 Excellence in clinical and translational research in Portugal
101060102
Investigador responsável
Instituto de Medicina Molecular, Portugal
Em curso
2023/06/01 - 2028/05/31 Plasmodium liver stage schizogony: high replication and genetic diversity
AdG - 101097801
Investigador responsável
Instituto de Medicina Molecular, Portugal
Em curso
2023/12/01 - 2026/11/30 Genetic variability in Plasmodium Liver Stage Schizogony
HR23-00499
Investigador responsável
Instituto de Medicina Molecular, Portugal
Em curso
2018/12/01 - 2021/11/30 Plasmodium Exploitation of Liver-specific Methionine Metabolism
HR17-00264
Investigador responsável
Instituto de Medicina Molecular, Portugal
 laCaixa Foundation
Concluído
2015/07/01 - 2021/06/30 Leverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection.
667824
10.3030/667824
Investigador responsável
Instituto de Medicina Molecular, Portugal
 European Commission
Concluído
2018/06/01 - 2021/05/31 Hepatic metabolism driving Plasmodium replication
LISBOA-01-0145-FEDER-030751
Investigador responsável
Instituto de Medicina Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluído
2016/04/01 - 2019/09/30 Evasion of host-mediated autophagy: mechanisms of Plasmodium survival in the liver-stage infection
FCT/PTDC/BIM-MEC/1342/2014
Investigador responsável
Instituto de Medicina Molecular, Portugal
 Fundação para a Ciência e a Tecnologia
Concluído
2016/01/01 - 2018/12/31 Unleash IMM’s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation
692022
10.3030/692022
Investigador responsável
Instituto de Medicina Molecular, Portugal
 European Commission
Concluído
2016/10/01 - 2018/09/30 Plasmodium autophagy evasion in the liver-stage: mechanisms and novel therapeutic opportunities
MRG_20052016
Investigador responsável
Instituto de Medicina Molecular, Portugal
 Institut Mérieux
Concluído
2016/11/01 - 2018/05/30 Drug Repurposing for Malaria Chemoprotection
PoC 713691
Investigador responsável
Instituto de Medicina Molecular, Portugal
 European Research Council
Concluído
2012/12 - 2017/11 Nutrient sensing by parasites
311502
Investigador responsável
Instituto de Medicina Molecular, Portugal
 European Research Council
Concluído
2013/04 - 2016/04 Animal models of human disease: refinement of strategies and implementation of new technologies
Provided by PTCRIS: 125967
 Fundação para a Ciência e a Tecnologia, I.P.
2013/01 - 2015/12 Host-Plasmodium interactions: a tale of sensing and being sensed
Provided by PTCRIS: 124777
Investigador responsável
Fundação para a Ciência e a Tecnologia, I.P.
Concluído
2010 - 2015 Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (EVIMalaR)
EVIMalaR
Outra
European Union
Concluído
2010/04 - 2013/09 New drugs for treating and eradicating malaria
Provided by PTCRIS: 110357
 Fundação para a Ciência e a Tecnologia, I.P.
2010/02 - 2013/01 Respiratory tract infections & malaria: a new case of mutual interactions?
Provided by PTCRIS: 108578
 Fundação para a Ciência e a Tecnologia, I.P.
2008/05 - 2011/04 The role of host cell kinases in Plasmodium development inside hepatocytes during the liver stage of malaria infections
Provided by PTCRIS: 72211
 Fundação para a Ciência e a Tecnologia, I.P.
2005 - 2010 Functional genomics in malaria - which are the host cell molecules and pathways required for Plasmodium development inside hepatocytes?
55005523
Investigador responsável
Howard Hughes Medical Institute
Concluído
2004 - 2009 The role of host cell factors in full development of the malaria parasite inside hepatocytes
EURYI – 2004
Investigador responsável
European Science Foundation
Concluído
2004 - 2009 The role of host cell factors in full development of the malaria parasite inside hepatocytes
EURYI 2004
 European Science Foundation
2007/01 - 2008/08 The role of Hemeoxygenase-1 and its products in the course and pathology of malaria infection.
Provided by PTCRIS: 82583
 Fundação para a Ciência e a Tecnologia, I.P.
2005 - 2007 Differential expression of malaria parasite invasion-associated proteins in sporozoite. Novel vaccination strategy (MALINV)
MALINV
Outra
European Union
Concluído
2005/09 - 2006/12 The role of Hemeoxygenase-1 and its products in the course and pathology of malaria infection.
Provided by PTCRIS: 57946
 Fundação para a Ciência e a Tecnologia, I.P.
2005/01 - 2006/12 The role of Plasmodium molecules that migrate to the host cell nucleus during the hepatocyte infection
Provided by PTCRIS: 61799
 Fundação para a Ciência e a Tecnologia, I.P.
2005/01 - 2006/12 Functional genomics in malaria - an unbias RNAi screen to determine the required host cell molecules and pathways for Plasmodium sporozoite fully development inside hepatocytes
Provided by PTCRIS: 60930
 Fundação para a Ciência e a Tecnologia, I.P.
2003/04 - 2006/03 Mechanism of action of Hepatocyte Growth Factor (HGF) released by sporozoite-wounded hepatocytes during malaria infection
Provided by PTCRIS: 44517
 Fundação para a Ciência e a Tecnologia, I.P.
2002/02 - 2005/02 Host-Parasite Interactions during the Hepatic Stages of Malaria Infections
Provided by PTCRIS: 38563
 Fundação para a Ciência e a Tecnologia, I.P.
Produções

Publicações

Artigo em revista
  1. Bento, Inês; Parrington, Brianna A.; Pascual, Rushlenne; Goldberg, Alexander S.; Wang, Eileen; Liu, Hani; Borrmann, Helene; et al. "Parasite and vector circadian clocks mediate efficient malaria transmission". Nature Microbiology (2025): https://doi.org/10.1038/s41564-025-01949-1.
    10.1038/s41564-025-01949-1
  2. Chantal T. Harris; Xinran Tong; Riward Campelo; Inês M. Marreiros; Leen N. Vanheer; Navid Nahiyaan; Vanessa A. Zuzarte-Luís; et al. "Sexual differentiation in human malaria parasites is regulated by competition between phospholipid metabolism and histone methylation". Nature Microbiology (2023): https://doi.org/10.1038/s41564-023-01396-w.
    10.1038/s41564-023-01396-w
  3. Aparajita Lahree; João Mello-Vieira; Maria M. Mota. "The nutrient games – Plasmodium metabolism during hepatic development". Trends in Parasitology (2023): https://doi.org/10.1016/j.pt.2023.03.013.
    10.1016/j.pt.2023.03.013
  4. Chora, Ângelo Ferreira; Marques, Sofia; Gonçalves, Joana Lisboa; Lima, Priscila; Gomes da Costa, Daniel; Fernandez-Ruiz, Daniel; Marreiros, Maria Inês; et al. "Interplay between liver and blood stages of Plasmodium infection dictates malaria severity via ¿d T cells and IL-17-promoted stress erythropoiesis". Immunity 56 3 (2023): 592-605.e8. http://dx.doi.org/10.1016/j.immuni.2023.01.031.
    10.1016/j.immuni.2023.01.031
  5. Inês M. Marreiros; Sofia Marques; Ana Parreira; Vincent Mastrodomenico; Bryan C. Mounce; Chantal T. Harris; Björn F. Kafsack; et al. "A non-canonical sensing pathway mediates Plasmodium adaptation to amino acid deficiency". Communications Biology (2023): https://doi.org/10.1038/s42003-023-04566-y.
    10.1038/s42003-023-04566-y
  6. Amichay Afriat; Vanessa Zuzarte-Luís; Keren Bahar Halpern; Lisa Buchauer; Sofia Marques; Ângelo Ferreira Chora; Aparajita Lahree; et al. "A spatiotemporally resolved single-cell atlas of the Plasmodium liver stage". Nature (2022): https://doi.org/10.1038/s41586-022-05406-5.
    10.1038/s41586-022-05406-5
  7. Chora, Ângelo Ferreira; Mota, Maria M.; Prudêncio, Miguel. "The reciprocal influence of the liver and blood stages of the malaria parasite's life cycle". International Journal for Parasitology 52 11 (2022): 711-715. http://dx.doi.org/10.1016/j.ijpara.2022.02.002.
    Publicado • 10.1016/j.ijpara.2022.02.002
  8. Mukherjee, Debanjan; Chora, Ângelo Ferreira; Lone, Jean-Christophe; Ramiro, Ricardo S.; Blankenhaus, Birte; Serre, Karine; Ramirez, Mário; et al. "Host lung microbiota promotes malaria-associated acute respiratory distress syndrome". Nature Communications 13 1 (2022): http://dx.doi.org/10.1038/s41467-022-31301-8.
    Publicado • 10.1038/s41467-022-31301-8
  9. Viriato M’Bana; Aparajita Lahree; Sofia Marques; Ksenija Slavic; Maria M. Mota. "Plasmodium parasitophorous vacuole membrane-resident protein UIS4 manipulates host cell actin to avoid parasite elimination". iScience (2022): https://doi.org/10.1016/j.isci.2022.104281.
    10.1016/j.isci.2022.104281
  10. Lahree, Aparajita; Baptista, Sara de Jesus Santos; Marques, Sofia; Perschin, Veronika; Zuzarte-Luís, Vanessa; Goel, Manisha; Choudhary, Hadi Hasan; et al. "Active APPL1 sequestration by Plasmodium favors liver-stage development". Cell Reports 39 9 (2022): 110886. http://dx.doi.org/10.1016/j.celrep.2022.110886.
    10.1016/j.celrep.2022.110886
  11. Canto e Castro, Luísa; Gomes, Andreia; Serrano, Marta; Pereira, Ana Helena Guia; Ribeiro, Rita; Napoleão, Patrícia; Domingues, Inês; et al. "Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after infection". European Journal of Immunology 52 1 (2021): 149-160. http://dx.doi.org/10.1002/eji.202149619.
    10.1002/eji.202149619
  12. Canto e Castro, Luísa; Pereira, Ana Helena Guia; Ribeiro, Rita; Alves, Catarina; Veloso, Luís; Vicente, Vera; Alves, Dalila; et al. "Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal". Emerging Infectious Diseases 27 11 (2021): 2878-2881. http://dx.doi.org/10.3201/eid2711.210636.
    10.3201/eid2711.210636
  13. João Mello-Vieira; Francisco J. Enguita; Tania F. de Koning-Ward; Vanessa Zuzarte-Luís; Maria M. Mota. "Plasmodium translocon component EXP2 facilitates hepatocyte invasion". Nature Communications (2020): https://doi.org/10.1038/s41467-020-19492-4.
    10.1038/s41467-020-19492-4
  14. Sonali Setua; Francisco J. Enguita; Ângelo Ferreira Chora; Harish Ranga-prasad; Aparajita Lahree; Sofia Marques; Varadharajan Sundaramurthy; Maria M. Mota. "Disrupting Plasmodium UIS3–host LC3 interaction with a small molecule causes parasite elimination from host cells". Communications Biology (2020): https://doi.org/10.1038/s42003-020-01422-1.
    10.1038/s42003-020-01422-1
  15. Balasubramanian, L.; Zuzarte-Luís, V.; Syed, T.; Mullick, D.; Deb, S.; Ranga-Prasad, H.; Meissner, J.; et al. "Association of Plasmodium berghei With the Apical Domain of Hepatocytes Is Necessary for the Parasite's Liver Stage Development". Frontiers in Cellular and Infection Microbiology 9 (2020): http://www.scopus.com/inward/record.url?eid=2-s2.0-85078863463&partnerID=MN8TOARS.
    10.3389/fcimb.2019.00451
  16. Mukherjee, D.; Chora, Â.F.; Mota, M.M.. "Microbiota, a Third Player in the Host–Plasmodium Affair". Trends in Parasitology 36 1 (2020): 11-18. http://www.scopus.com/inward/record.url?eid=2-s2.0-85075853824&partnerID=MN8TOARS.
    10.1016/j.pt.2019.11.001
  17. Vera, Iset Medina; Grilo Ruivo, Margarida T.; Lemos Rocha, Leonardo F.; Marques, Sofia; Bhatia, Sangeeta N.; Mota, Maria M.; Mancio-Silva, Liliana. "Targeting liver stage malaria with metformin". JCI Insight 4 24 (2019): http://dx.doi.org/10.1172/jci.insight.127441.
    10.1172/jci.insight.127441
  18. de Menezes, M.N.; Salles, É.M.; Vieira, F.; Amaral, E.P.; Zuzarte-Luís, V.; Cassado, A.; Epiphanio, S.; et al. "IL-1a promotes liver inflammation and necrosis during blood-stage Plasmodium chabaudi malaria". Scientific Reports 9 1 (2019): http://www.scopus.com/inward/record.url?eid=2-s2.0-85065972196&partnerID=MN8TOARS.
    10.1038/s41598-019-44125-2
  19. Ribot, J.C.; Neres, R.; Zuzarte-Luís, V.; Gomes, A.Q.; Mancio-Silva, L.; Mensurado, S.; Pinto-Neves, D.; et al. "¿d-T cells promote IFN-¿–dependent Plasmodium pathogenesis upon liver-stage infection". Proceedings of the National Academy of Sciences of the United States of America 116 20 (2019): 9979-9988. http://www.scopus.com/inward/record.url?eid=2-s2.0-85065721677&partnerID=MN8TOARS.
    10.1073/pnas.1814440116
  20. Mota, M.M.; Mello-Vieira, J.. "Parasitism: Anopheles Mosquitoes and Plasmodium Parasites Share Resources". Current Biology 29 13 (2019): R632-R634. http://www.scopus.com/inward/record.url?eid=2-s2.0-85068175719&partnerID=MN8TOARS.
    10.1016/j.cub.2019.05.030
  21. Zuzarte-Luís, V.; Mota, M.M.. "Parasite Sensing of Host Nutrients and Environmental Cues". Cell Host and Microbe 23 6 (2018): 749-758. http://www.scopus.com/inward/record.url?eid=2-s2.0-85047948675&partnerID=MN8TOARS.
    10.1016/j.chom.2018.05.018
  22. Mendes, A.M.; Machado, M.; Gonçalves-Rosa, N.; Reuling, I.J.; Foquet, L.; Marques, C.; Salman, A.M.; et al. "A Plasmodium berghei sporozoite-based vaccination platform against human malaria". npj Vaccines 3 1 (2018): http://www.scopus.com/inward/record.url?eid=2-s2.0-85052199174&partnerID=MN8TOARS.
    10.1038/s41541-018-0068-2
  23. Armistead, J.S.; Jennison, C.; O'Neill, M.T.; Lopaticki, S.; Liehl, P.; Hanson, K.K.; Annoura, T.; et al. "Plasmodium falciparum subtilisin-like ookinete protein SOPT plays an important and conserved role during ookinete infection of the Anopheles stephensi midgut". Molecular Microbiology 109 4 (2018): 458-473. http://www.scopus.com/inward/record.url?eid=2-s2.0-85053478759&partnerID=MN8TOARS.
    10.1111/mmi.13993
  24. Zuzarte-Luis, V.; Mota, M.M.. "Fighting for Resources: Who Started the Battle? Who Is Winning It?". Cell Metabolism 27 4 (2018): 708-709. http://www.scopus.com/inward/record.url?eid=2-s2.0-85044530685&partnerID=MN8TOARS.
    10.1016/j.cmet.2018.03.007
  25. Vanessa Zuzarte-Luís; João Mello-Vieira; Inês M. Marreiros; Peter Liehl; Ângelo F. Chora; Céline K. Carret; Tânia Carvalho; Maria M. Mota. "Dietary alterations modulate susceptibility to Plasmodium infection". Nature Microbiology 2 12 (2017): 1600-1607. https://doi.org/10.1038/s41564-017-0025-2.
    10.1038/s41564-017-0025-2
  26. Eliana Real; Lénia Rodrigues; Ghislain G. Cabal; Francisco J. Enguita; Liliana Mancio-Silva; João Mello-Vieira; Wandy Beatty; et al. "Plasmodium UIS3 sequesters host LC3 to avoid elimination by autophagy in hepatocytes". Nature Microbiology (2017): https://doi.org/10.1038/s41564-017-0054-x.
    10.1038/s41564-017-0054-x
  27. Sá E Cunha, C.; Nyboer, B.; Heiss, K.; Sanches-Vaz, M.; Fontinha, D.; Wiedtke, E.; Grimm, D.; et al. "Plasmodium berghei EXP-1 interacts with host Apolipoprotein H during Plasmodium liver-stage development". Proceedings of the National Academy of Sciences of the United States of America 114 7 (2017): E1138-E1147. http://www.scopus.com/inward/record.url?eid=2-s2.0-85012991824&partnerID=MN8TOARS.
    10.1073/pnas.1606419114
  28. Mancio-Silva, L.; Slavic, K.; Grilo Ruivo, M.T.; Grosso, A.R.; Modrzynska, K.K.; Vera, I.M.; Sales-Dias, J.; et al. "Nutrient sensing modulates malaria parasite virulence". Nature 547 7662 (2017): 213-216. http://www.scopus.com/inward/record.url?eid=2-s2.0-85024370548&partnerID=MN8TOARS.
    10.1038/nature23009
  29. Tanowitz, H.B.; Scherer, P.E.; Mota, M.M.; Figueiredo, L.M.. "Adipose Tissue: A Safe Haven for Parasites?". Trends in Parasitology 33 4 (2017): 276-284. http://www.scopus.com/inward/record.url?eid=2-s2.0-85008413087&partnerID=MN8TOARS.
    10.1016/j.pt.2016.11.008
  30. Ng, S.; March, S.; Galstian, A.; Gural, N.; Stevens, K.R.; Mota, M.M.; Bhatia, S.N.. "Towards a Humanized Mouse Model of Liver Stage Malaria Using Ectopic Artificial Livers". Scientific Reports 7 (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85016564235&partnerID=MN8TOARS.
    10.1038/srep45424
  31. Slavic K; Krishna S; Lahree A; Bouyer G; Hanson KK; Vera I; Pittman JK; Staines HM; Mota MM. "A vacuolar iron-transporter homologue acts as a detoxifier in Plasmodium.". (2016): http://europepmc.org/abstract/med/26786069.
    10.1038/ncomms10403
  32. Ruivo, M.T.G.; Vera, I.M.; Sales-Dias, J.; Meireles, P.; Gural, N.; Bhatia, S.N.; Mota, M.M.; Mancio-Silva, L.. "Host AMPK Is a Modulator of Plasmodium Liver Infection". Cell Reports 16 10 (2016): 2539-2545. http://www.scopus.com/inward/record.url?eid=2-s2.0-85006445957&partnerID=MN8TOARS.
    10.1016/j.celrep.2016.08.001
  33. Thieleke-Matos, C.; Lopes da Silva, M.; Cabrita-Santos, L.; Portal, M.D.; Rodrigues, I.P.; Zuzarte-Luis, V.; Ramalho, J.S.; et al. "Host cell autophagy contributes to Plasmodium liver development". Cellular Microbiology 18 3 (2016): 437-450. http://www.scopus.com/inward/record.url?eid=2-s2.0-84958112950&partnerID=MN8TOARS.
    10.1111/cmi.12524
  34. March S; Ramanan V; Trehan K; Ng S; Galstian A; Gural N; Scull MA; et al. "Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens.". (2015): http://europepmc.org/abstract/med/26584444.
    10.1038/nprot.2015.128
  35. Liehl P; Zuzarte-Luis V; Mota MM. "Unveiling the pathogen behind the vacuole.". (2015): http://europepmc.org/abstract/med/26189591.
    10.1038/nrmicro3504
  36. Inácio P; Zuzarte-Luís V; Ruivo MT; Falkard B; Nagaraj N; Rooijers K; Mann M; et al. "Parasite-induced ER stress response in hepatocytes facilitates Plasmodium liver stage infection.". (2015): http://europepmc.org/abstract/med/26113366.
    10.15252/embr.201439979
  37. Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; et al. "The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.". (2015): http://europepmc.org/abstract/med/25995223.
    10.1126/scitranslmed.aaa3575
  38. Mancio-Silva L; Mota MM. "A mediator for malaria stickiness in A versus O blood.". (2015): http://europepmc.org/abstract/med/25849268.
    10.1038/nm.3837
  39. Peter Liehl; Patrícia Meireles; Inês S. Albuquerque; Mykola Pinkevych; Fernanda Baptista; Maria M. Mota; Miles P. Davenport; Miguel Prudêncio; J. H. Adams. "Innate Immunity Induced by Plasmodium Liver Infection Inhibits Malaria Reinfections". Infection and Immunity 83 3 (2015): 1172-1180. http://dx.doi.org/10.1128/IAI.02796-14.
    10.1128/IAI.02796-14
  40. Ng S; Schwartz RE; March S; Galstian A; Gural N; Shan J; Prabhu M; Mota MM; Bhatia SN. "Human iPSC-derived hepatocyte-like cells support Plasmodium liver-stage infection in vitro.". (2015): http://europepmc.org/abstract/med/25660406.
    10.1016/j.stemcr.2015.01.002
  41. Hanson KK; March S; Ng S; Bhatia SN; Mota MM. "In vitro alterations do not reflect a requirement for host cell cycle progression during Plasmodium liver stage infection.". (2015): http://europepmc.org/abstract/med/25416236.
    10.1128/EC.00166-14
  42. Veigas B; Pedrosa P; Carlos FF; Mancio-Silva L; Grosso AR; Fortunato E; Mota MM; Baptista PV. "One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care.". (2015): http://europepmc.org/abstract/med/26250828.
    10.1186/s12951-015-0109-1
  43. Itoe MA; Sampaio JL; Cabal GG; Real E; Zuzarte-Luis V; March S; Bhatia SN; et al. "Host cell phosphatidylcholine is a key mediator of malaria parasite survival during liver stage infection.". (2014): http://europepmc.org/abstract/med/25498345.
    10.1016/j.chom.2014.11.006
  44. Carballeira NM; Bwalya AG; Itoe MA; Andricopulo AD; Cordero-Maldonado ML; Kaiser M; Mota MM; et al. "2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.". (2014): http://europepmc.org/abstract/med/25103602.
    10.1016/j.bmcl.2014.07.050
  45. Derbyshire ER; Zuzarte-Luís V; Magalhães AD; Kato N; Sanschagrin PC; Wang J; Zhou W; et al. "Chemical interrogation of the malaria kinome.". (2014): http://europepmc.org/abstract/med/25111632.
    10.1002/cbic.201400025
  46. Zuzarte-Luis V; Mota MM; Vigário AM. "Malaria infections: what and how can mice teach us.". (2014): http://europepmc.org/abstract/med/24837740.
    10.1016/j.jim.2014.05.001
  47. Liehl, P.; Zuzarte-Luís, V.; Chan, J.; Zillinger, T.; Baptista, F.; Carapau, D.; Konert, M.; et al. "Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection". Nature Medicine 20 1 (2014): 47-53. http://www.scopus.com/inward/record.url?eid=2-s2.0-84891874162&partnerID=MN8TOARS.
    10.1038/nm.3424
  48. Frischknecht, F.; Mota, M.; Scherf, A.; Waters, A.. "Biology of the Malaria Parasite - editorial on the special issue for the 10th BioMalPar conference". Cellular Microbiology 16 5 (2014): 599-601. http://www.scopus.com/inward/record.url?eid=2-s2.0-84898400277&partnerID=MN8TOARS.
    10.1111/cmi.12295
  49. Ng, S.; March, S.; Galstian, A.; Hanson, K.; Carvalho, T.; Mota, M.M.; Bhatia, S.N.. "Hypoxia promotes liver-stage malaria infection in primary human hepatocytes in vitro". DMM Disease Models and Mechanisms 7 2 (2014): 215-224. http://www.scopus.com/inward/record.url?eid=2-s2.0-84894305879&partnerID=MN8TOARS.
    10.1242/dmm.013490
  50. Miranda, D.; Capela, R.; Albuquerque, I.S.; Meireles, P.; Paiva, I.; Nogueira, F.; Amewu, R.; et al. "Novel endoperoxide-based transmission-blocking antimalarials with liver- and blood-schizontocidal activities". ACS Medicinal Chemistry Letters 5 2 (2014): 108-112. http://www.scopus.com/inward/record.url?eid=2-s2.0-84894075620&partnerID=MN8TOARS.
    10.1021/ml4002985
  51. Zuzarte-Luis, V.; Sales-Dias, J.; Mota, M.M.. "Simple, sensitive and quantitative bioluminescence assay for determination of malaria pre-patent period". Malaria Journal 13 1 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84892167814&partnerID=MN8TOARS.
    10.1186/1475-2875-13-15
  52. Rodrigues T; Ressurreição AS; da Cruz FP; Albuquerque IS; Gut J; Carrasco MP; Gonçalves D; et al. "Flavones as isosteres of 4(1H)-quinolones: Discovery of ligand efficient and dual stage antimalarial lead compounds.". (2013): http://europepmc.org/abstract/med/24125849.
    10.1016/j.ejmech.2013.09.008
  53. Ressurreição AS; Gonçalves D; Sitoe AR; Albuquerque IS; Gut J; Góis A; Gonçalves LM; et al. "Structural optimization of Quinolon-4(1H)-imines as dual-stage antimalarials: toward increased potency and metabolic stability.". (2013): http://europepmc.org/abstract/med/24020770.
    10.1021/jm4011466
  54. March S; Ng S; Velmurugan S; Galstian A; Shan J; Logan DJ; Carpenter AE; et al. "A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax.". (2013): http://europepmc.org/abstract/med/23870318.
    10.1016/j.chom.2013.06.005
  55. Hanson KK; Ressurreição AS; Buchholz K; Prudêncio M; Herman-Ornelas JD; Rebelo M; Beatty WL; et al. "Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins.". (2013): http://europepmc.org/abstract/med/23836641.
    10.1073/pnas.1306097110
  56. Rodrigues T; da Cruz FP; Lafuente-Monasterio MJ; Gonçalves D; Ressurreição AS; Sitoe AR; Bronze MR; et al. "Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria.". (2013): http://europepmc.org/abstract/med/23701465.
    10.1021/jm400246e
  57. Rebelo M; Sousa C; Shapiro HM; Mota MM; Grobusch MP; Hänscheid T. "A novel flow cytometric hemozoin detection assay for real-time sensitivity testing of Plasmodium falciparum.". (2013): http://europepmc.org/abstract/med/23637865.
    10.1371/journal.pone.0061606
  58. Prudêncio M; Mota MM. "Targeting host factors to circumvent anti-malarial drug resistance.". (2013): http://europepmc.org/abstract/med/22973886.
    10.2174/138161213804070276
  59. Spavieri, J.; Allmendinger, A.; Kaiser, M.; Itoe, M.A.; Blunden, G.; Mota, M.M.; Tasdemir, D.. "Assessment of dual life stage antiplasmodial activity of British seaweeds". Marine Drugs 11 10 (2013): 4019-4034. http://www.scopus.com/inward/record.url?eid=2-s2.0-84887065721&partnerID=MN8TOARS.
    10.3390/md11104019
  60. Gomes-Santos CS; Itoe MA; Afonso C; Henriques R; Gardner R; Sepúlveda N; Simões PD; et al. "Highly dynamic host actin reorganization around developing Plasmodium inside hepatocytes.". (2012): http://europepmc.org/abstract/med/22238609.
    10.1371/journal.pone.0029408
  61. Frita R; Carapau D; Mota MM; Hänscheid T. "In Vivo Hemozoin Kinetics after Clearance of Plasmodium berghei Infection in Mice.". (2012): http://europepmc.org/abstract/med/22567535.
    10.1155/2012/373086
  62. Rodrigues, T.; Prudêncio, M.; Moreira, R.; Mota, M.M.; Lopes, F.. "Targeting the liver stage of malaria parasites: A yet unmet goal". Journal of Medicinal Chemistry 55 3 (2012): 995-1012. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856909677&partnerID=MN8TOARS.
    10.1021/jm201095h
  63. Eaton, P.; Zuzarte-Luis, V.; Mota, M.M.; Santos, N.C.; Prudêncio, M.. "Infection by Plasmodium changes shape and stiffness of hepatic cells". Nanomedicine: Nanotechnology, Biology, and Medicine 8 1 (2012): 17-19. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855332785&partnerID=MN8TOARS.
    10.1016/j.nano.2011.10.004
  64. Guirgis, B.S.S.; Sá E Cunha, C.; Gomes, I.; Cavadas, M.; Silva, I.; Doria, G.; Blatch, G.L.; et al. "Gold nanoparticle-based fluorescence immunoassay for malaria antigen detection". Analytical and Bioanalytical Chemistry 402 3 (2012): 1019-1027. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856211668&partnerID=MN8TOARS.
    10.1007/s00216-011-5489-y
  65. Liehl, P.; Mota, M.M.. "Innate recognition of malarial parasites by mammalian hosts". International Journal for Parasitology 42 6 (2012): 557-566. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861714135&partnerID=MN8TOARS.
    10.1016/j.ijpara.2012.04.006
  66. da Silva, H.B.; Caetano, S.S.; Monteiro, I.; Gómez-Conde, I.; Hanson, K.; Penha-Gonçalves, C.; Olivieri, D.N.; et al. "Early skin immunological disturbance after Plasmodium-infected mosquito bites". Cellular Immunology 277 1-2 (2012): 22-32. http://www.scopus.com/inward/record.url?eid=2-s2.0-84864296246&partnerID=MN8TOARS.
    10.1016/j.cellimm.2012.06.003
  67. Da Cruz, F.P.; Martin, C.; Buchholz, K.; Lafuente-Monasterio, M.J.; Rodrigues, T.; Sönnichsen, B.; Moreira, R.; et al. "Drug screen targeted at plasmodium liver stages identifies a potent multistage antimalarial drug". Journal of Infectious Diseases 205 8 (2012): 1278-1286. http://www.scopus.com/inward/record.url?eid=2-s2.0-84859080629&partnerID=MN8TOARS.
    10.1093/infdis/jis184
  68. Pena, A.C.; Penacho, N.; Mancio-Silva, L.; Neres, R.; Seixas, J.D.; Fernandes, A.C.; Romão, C.C.; et al. "A novel carbon monoxide-releasing molecule fully protects mice from severe malaria". Antimicrobial Agents and Chemotherapy 56 3 (2012): 1281-1290. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857153465&partnerID=MN8TOARS.
    10.1128/AAC.05571-11
  69. Derbyshire, E.R.; Prudêncio, M.; Mota, M.M.; Clardy, J.. "Liver-stage malaria parasites vulnerable to diverse chemical scaffolds". Proceedings of the National Academy of Sciences of the United States of America 109 22 (2012): 8511-8516. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861904136&partnerID=MN8TOARS.
    10.1073/pnas.1118370109
  70. Portugal S; Drakesmith H; Mota MM. "Superinfection in malaria: Plasmodium shows its iron will.". (2011): http://europepmc.org/abstract/med/22081142.
    10.1038/embor.2011.213
  71. Prudêncio M; Mota MM; Mendes AM. "A toolbox to study liver stage malaria.". (2011): http://europepmc.org/abstract/med/22015112.
    10.1016/j.pt.2011.09.004
  72. Capela R; Cabal GG; Rosenthal PJ; Gut J; Mota MM; Moreira R; Lopes F; Prudêncio M. "Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy.". (2011): http://europepmc.org/abstract/med/21807973.
    10.1128/AAC.05133-11
  73. Derbyshire ER; Mota MM; Clardy J. "The next opportunity in anti-malaria drug discovery: the liver stage.". (2011): http://europepmc.org/abstract/med/21966266.
    10.1371/journal.ppat.1002178
  74. Portugal S; Carret C; Recker M; Armitage AE; Gonçalves LA; Epiphanio S; Sullivan D; et al. "Host-mediated regulation of superinfection in malaria.". (2011): http://europepmc.org/abstract/med/21572427.
    10.1038/nm.2368
  75. Slavic K; Delves MJ; Prudêncio M; Talman AM; Straschil U; Derbyshire ET; Xu Z; et al. "Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle.". (2011): http://europepmc.org/abstract/med/21402842.
    10.1128/AAC.01739-10
  76. Gomes-Santos CS; Braks J; Prudêncio M; Carret C; Gomes AR; Pain A; Feltwell T; et al. "Transition of Plasmodium sporozoites into liver stage-like forms is regulated by the RNA binding protein Pumilio.". (2011): http://europepmc.org/abstract/med/21625527.
    10.1371/journal.ppat.1002046
  77. Lavrado J; Cabal GG; Prudêncio M; Mota MM; Gut J; Rosenthal PJ; Díaz C; et al. "Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies.". (2011): http://europepmc.org/abstract/med/21207937.
    10.1021/jm101383f
  78. Frita R; Rebelo M; Pamplona A; Vigario AM; Mota MM; Grobusch MP; Hänscheid T. "Simple flow cytometric detection of haemozoin containing leukocytes and erythrocytes for research on diagnosis, immunology and drug sensitivity testing.". (2011): http://europepmc.org/abstract/med/21453521.
    10.1186/1475-2875-10-74
  79. Liesenfeld O; Parvanova I; Zerrahn J; Han SJ; Heinrich F; Muñoz M; Kaiser F; et al. "The IFN-¿-inducible GTPase, Irga6, protects mice against Toxoplasma gondii but not against Plasmodium berghei and some other intracellular pathogens.". (2011): http://europepmc.org/abstract/med/21698150.
    10.1371/journal.pone.0020568
  80. Langhorne J; Buffet P; Galinski M; Good M; Harty J; Leroy D; Mota MM; et al. "The relevance of non-human primate and rodent malaria models for humans.". (2011): http://europepmc.org/abstract/med/21288352.
    10.1186/1475-2875-10-23
  81. Douradinha B; Augustijn KD; Moore SG; Ramesar J; Mota MM; Waters AP; Janse CJ; Thompson J. "Plasmodium Cysteine Repeat Modular Proteins 3 and 4 are essential for malaria parasite transmission from the mosquito to the host.". (2011): http://europepmc.org/abstract/med/21453484.
    10.1186/1475-2875-10-71
  82. Douradinha B; van Dijk M; van Gemert GJ; Khan SM; Janse CJ; Waters AP; Sauerwein RW; et al. "Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver.". (2011): http://europepmc.org/abstract/med/22004696.
    10.1186/1476-8518-9-6
  83. Rodriguez, A.; Mota, M.M.. "The crucial role of hepatocyte growth factor receptor during liver-stage infection is not conserved among Plasmodium species". Nature Medicine 17 10 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-80053981304&partnerID=MN8TOARS.
    10.1038/nm.2487
  84. Portugal, S.; Armitage, A.E.; Newbold, C.I.; Drakesmith, H.; Mota, M.M.. "Portugal, Armitage, Newbold, Drakesmith and Mota reply". Nature Medicine 17 11 (2011): 1341-1342. http://www.scopus.com/inward/record.url?eid=2-s2.0-81255143046&partnerID=MN8TOARS.
    10.1038/nm.2511
  85. Baptista FG; Pamplona A; Pena AC; Mota MM; Pied S; Vigário AM. "Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice.". (2010): http://europepmc.org/abstract/med/20605973.
    10.1128/IAI.00079-10
  86. Epiphanio S; Campos MG; Pamplona A; Carapau D; Pena AC; Ataíde R; Monteiro CA; et al. "VEGF promotes malaria-associated acute lung injury in mice.". (2010): http://europepmc.org/abstract/med/20502682.
    10.1371/journal.ppat.1000916
  87. Liehl P; França AR; Prudêncio M; Latz E; Zaidman-Rémy A; Mota MM. "Phosphothioate oligodeoxynucleotides inhibit Plasmodium sporozoite gliding motility.". (2010): http://europepmc.org/abstract/med/19912239.
    10.1111/j.1462-5822.2009.01411.x
  88. Gomes-Santos CS; Braks JAM; Prudêncio M; Carret CK; Gomes AR; Pain A; Feltwell T; et al. "Developmental transition of Plasmodium sporozoites into liver-stage forms is regulated by the RNA binding protein Pumilio 2.". (2010): http://europepmc.org/abstract/PMC/PMC2963252.
  89. Vale N; Prudêncio M; Marques CA; Collins MS; Gut J; Nogueira F; Matos J; et al. "Imidazoquines as antimalarial and antipneumocystis agents.". (2009): http://europepmc.org/abstract/med/19799426.
    10.1021/jm900738c
  90. Prudêncio M; Derbyshire ET; Marques CA; Krishna S; Mota MM; Staines HM. "Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cells.". (2009): http://europepmc.org/abstract/med/19496788.
    10.1111/j.1462-5822.2009.01342.x
  91. Pamplona A; Hanscheid T; Epiphanio S; Mota MM; Vigário AM. "Cerebral malaria and the hemolysis/methemoglobin/heme hypothesis: shedding new light on an old disease.". (2009): http://europepmc.org/abstract/med/18930163.
    10.1016/j.biocel.2008.09.020
  92. Parvanova I; Epiphanio S; Fauq A; Golde TE; Prudêncio M; Mota MM. "A small molecule inhibitor of signal peptide peptidase inhibits Plasmodium development in the liver and decreases malaria severity.". (2009): http://europepmc.org/abstract/med/19337374.
    10.1371/journal.pone.0005078
  93. Ploemen IH; Prudêncio M; Douradinha BG; Ramesar J; Fonager J; van Gemert GJ; Luty AJ; et al. "Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging.". (2009): http://europepmc.org/abstract/med/19924309.
    10.1371/journal.pone.0007881
  94. Albuquerque SS; Carret C; Grosso AR; Tarun AS; Peng X; Kappe SH; Prudêncio M; Mota MM. "Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events.". (2009): http://europepmc.org/abstract/med/19534804.
    10.1186/1471-2164-10-270
  95. Bagnaresi P; Alves E; da Silva HB; Epiphanio S; Mota MM; Garcia CR; Bagnaresi, P.; et al. "Unlike the synchronous Plasmodium falciparum and P. chabaudi infection, the P. berghei and P. yoelii asynchronous infections are not affected by melatonin.". International Journal of General Medicine 2 (2009): 47-55. http://europepmc.org/abstract/med/20360886.
  96. Frischknecht, F.; Mota, M.; Way, M.; Shorte, S.. "Perspective: Hidden treasures from the archives". Biotechnology Journal 4 6 (2009): 784-785. http://www.scopus.com/inward/record.url?eid=2-s2.0-68049115400&partnerID=MN8TOARS.
    10.1002/biot.200900103
  97. Prudêncio M; Rodrigues CD; Hannus M; Martin C; Real E; Gonçalves LA; Carret C; et al. "Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection.". (2008): http://europepmc.org/abstract/med/18989463.
    10.1371/journal.ppat.1000201
  98. Rodrigues CD; Hannus M; Prudêncio M; Martin C; Gonçalves LA; Portugal S; Epiphanio S; et al. "Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection.". (2008): http://europepmc.org/abstract/med/18779053.
    10.1016/j.chom.2008.07.012
  99. Silvie O; Mota MM; Matuschewski K; Prudêncio M. "Interactions of the malaria parasite and its mammalian host.". (2008): http://europepmc.org/abstract/med/18644249.
    10.1016/j.mib.2008.06.005
  100. Epiphanio S; Mikolajczak SA; Gonçalves LA; Pamplona A; Portugal S; Albuquerque S; Goldberg M; et al. "Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection.". (2008): http://europepmc.org/abstract/med/18474360.
    10.1016/j.chom.2008.04.003
  101. Douradinha B; Mota MM; Luty AJ; Sauerwein RW. "Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?". (2008): http://europepmc.org/abstract/med/18056479.
    10.1128/IAI.00431-07
  102. Mota MM; Rodriguez A. "New pieces for the malaria liver stage puzzle: where will they fit?". (2008): http://europepmc.org/abstract/med/18312840.
    10.1016/j.chom.2008.01.004
  103. Ono T; Cabrita-Santos L; Leitao R; Bettiol E; Purcell LA; Diaz-Pulido O; Andrews LB; et al. "Adenylyl cyclase alpha and cAMP signaling mediate Plasmodium sporozoite apical regulated exocytosis and hepatocyte infection.". (2008): http://europepmc.org/abstract/med/18389080.
    10.1371/journal.ppat.1000008
  104. Prudêncio M; Rodrigues CD; Ataíde R; Mota MM. "Dissecting in vitro host cell infection by Plasmodium sporozoites using flow cytometry.". (2008): http://europepmc.org/abstract/med/17697130.
    10.1111/j.1462-5822.2007.01032.x
  105. Cunha-Rodrigues M; Portugal S; Prudêncio M; Gonçalves LA; Casalou C; Buger D; Sauerwein R; Haas W; Mota MM. "Genistein-supplemented diet decreases malaria liver infection in mice and constitutes a potential prophylactic strategy.". (2008): http://europepmc.org/abstract/med/18628947.
    10.1371/journal.pone.0002732
  106. Douradinha B; van Dijk MR; Ataide R; van Gemert GJ; Thompson J; Franetich JF; Mazier D; et al. "Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection.". (2007): http://europepmc.org/abstract/med/17604034.
    10.1016/j.ijpara.2007.05.005
  107. Pamplona A; Clark IA; Mota MM. "Severe malaria increases the list of heme oxygenase-1-protected diseases.". (2007): http://europepmc.org/abstract/med/17683270.
    10.2217/17460913.2.4.361
  108. Carapau D; Kruhofer M; Chatalbash A; Orengo JM; Mota MM; Rodriguez A. "Transcriptome profile of dendritic cells during malaria: cAMP regulation of IL-6.". (2007): http://europepmc.org/abstract/med/17324158.
    10.1111/j.1462-5822.2007.00910.x
  109. Pamplona A; Ferreira A; Balla J; Jeney V; Balla G; Epiphanio S; Chora A; et al. "Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria.". (2007): http://europepmc.org/abstract/med/17496899.
    10.1038/nm1586
  110. Cunha-Rodrigues M; Portugal S; Febbraio M; Mota MM. "Bone marrow chimeric mice reveal a dual role for CD36 in Plasmodium berghei ANKA infection.". (2007): http://europepmc.org/abstract/med/17367535.
    10.1186/1475-2875-6-32
  111. Prudêncio, M.; Mota, M.M.; Prudêncio M; Mota MM. "To Migrate or to Invade: Those Are the Options". Cell Host and Microbe 2 5 (2007): 286-288. http://www.scopus.com/inward/record.url?eid=2-s2.0-35848952084&partnerID=MN8TOARS.
    10.1016/j.chom.2007.10.008
  112. Prudêncio, M.; Rodrigues, C.D.; Mota, M.M.; Prudêncio M; Rodrigues CD; Mota MM. "The relevance of host genes in malaria.". SEB experimental biology series 58 (2007): 47-91. http://www.scopus.com/inward/record.url?eid=2-s2.0-34748813828&partnerID=MN8TOARS.
  113. Prudêncio M; Rodriguez A; Mota MM. "The silent path to thousands of merozoites: the Plasmodium liver stage.". (2006): http://europepmc.org/abstract/med/17041632.
    10.1038/nrmicro1529
  114. Mota MM. "Be in motion . . .". (2006): http://europepmc.org/abstract/med/16796671.
    10.1111/j.1365-2958.2006.05192.x
  115. Jongco AM; Ting LM; Thathy V; Mota MM; Kim K. "Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.". (2006): http://europepmc.org/abstract/med/16458371.
    10.1016/j.molbiopara.2006.01.001
  116. Cunha-Rodrigues M; Prudêncio M; Mota MM; Haas W; Cunha-Rodrigues, M.; Prudêncio, M.; Mota, M.M.; Haas, W.. "Antimalarial drugs - host targets (re)visited.". Biotechnology Journal 1 3 (2006): 321-332. http://europepmc.org/abstract/med/16897712.
    10.1002/biot.200500038
  117. Cunha-Rodrigues M; Portugal S; Febbraio M; Mota MM. "Infection by and protective immune responses against Plasmodium berghei ANKA are not affected in macrophage scavenger receptors A deficient mice.". (2006): http://europepmc.org/abstract/med/16914051.
    10.1186/1471-2180-6-73
  118. Leiriao, P.; Mota, M.M.; Rodriguez, A.. "Reply to Rénia et al. [2]". Journal of Infectious Diseases 193 1 (2006): 164-165. http://www.scopus.com/inward/record.url?eid=2-s2.0-29744439712&partnerID=MN8TOARS.
    10.1086/498537
  119. Franke-Fayard B; Janse CJ; Cunha-Rodrigues M; Ramesar J; Büscher P; Que I; Löwik C; et al. "Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration.". (2005): http://europepmc.org/abstract/med/16051702.
    10.1073/pnas.0503386102
  120. van Dijk MR; Douradinha B; Franke-Fayard B; Heussler V; van Dooren MW; van Schaijk B; van Gemert GJ; et al. "Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells.". (2005): http://europepmc.org/abstract/med/16103357.
    10.1073/pnas.0500925102
  121. Leiriao P; Mota MM; Rodriguez A. "Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells.". (2005): http://europepmc.org/abstract/med/15838783.
    10.1086/429635
  122. Leirião P; Albuquerque SS; Corso S; van Gemert GJ; Sauerwein RW; Rodriguez A; Giordano S; Mota MM. "HGF/MET signalling protects Plasmodium-infected host cells from apoptosis.". (2005): http://europepmc.org/abstract/med/15760460.
    10.1111/j.1462-5822.2004.00490.x
  123. Waters AP; Mota MM; van Dijk MR; Janse CJ. "Parasitology. Malaria vaccines: back to the future?". (2005): http://europepmc.org/abstract/med/15681372.
    10.1126/science.1108598
  124. Mota MM; Rodriguez A. "Migration through host cells: the first steps of Plasmodium sporozoites in the mammalian host.". (2004): http://europepmc.org/abstract/med/15527491.
    10.1111/j.1462-5822.2004.00460.x
  125. Leirião P; Rodrigues CD; Albuquerque SS; Mota MM. "Survival of protozoan intracellular parasites in host cells.". (2004): http://europepmc.org/abstract/med/15577928.
    10.1038/sj.embor.7400299
  126. Mota MM; Giordano S; Rodriguez A. "Targeting Plasmodium host cells: survival within hepatocytes.". (2004): http://europepmc.org/abstract/med/15464448.
    10.1016/j.molmed.2004.08.003
  127. Sanchez BA; Mota MM; Sultan AA; Carvalho LH. "Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents.". (2004): http://europepmc.org/abstract/med/15013738.
    10.1016/j.ijpara.2003.11.011
  128. Mota, M.M.. "Malaria sporozoite: Migrating for a living - A response". Trends in Molecular Medicine 10 3 (2004): 100-101. http://www.scopus.com/inward/record.url?eid=2-s2.0-1442323839&partnerID=MN8TOARS.
    10.1016/j.molmed.2004.01.011
  129. Carrolo M; Giordano S; Cabrita-Santos L; Corso S; Vigário AM; Silva S; Leirião P; et al. "Hepatocyte growth factor and its receptor are required for malaria infection.". (2003): http://europepmc.org/abstract/med/14556002.
    10.1038/nm947
  130. Ocaña-Morgner C; Mota MM; Rodriguez A. "Malaria blood stage suppression of liver stage immunity by dendritic cells.". (2003): http://europepmc.org/abstract/med/12538654.
    10.1084/jem.20021072
  131. Mota, M.M.; Hafalla, J.C.R.; Rodriguez, A.. "Erratum: Migration through host cells activates Plasmodium sporozoites for infection (Nature Medicine (2002) 8 (1318-1322))". Nature Medicine 9 1 (2003): http://www.scopus.com/inward/record.url?eid=2-s2.0-0037234456&partnerID=MN8TOARS.
    10.1038/nm0103-146a
  132. Mota MM; Hafalla JC; Rodriguez A. "Migration through host cells activates Plasmodium sporozoites for infection.". (2002): http://europepmc.org/abstract/med/12379848.
    10.1038/nm785
  133. Delrieu I; Waller CC; Mota MM; Grainger M; Langhorne J; Holder AA. "PSLAP, a protein with multiple adhesive motifs, is expressed in Plasmodium falciparum gametocytes.". (2002): http://europepmc.org/abstract/med/11985859.
    10.1016/S0166-6851(02)00016-6
  134. Mota MM; Rodriguez A. "Invasion of mammalian host cells by Plasmodium sporozoites.". (2002): http://europepmc.org/abstract/med/11835279.
    10.1002/bies.10050
  135. Mota MM; Rodriguez A. "Migration through host cells by apicomplexan parasites.". (2001): http://europepmc.org/abstract/med/11709293.
    10.1016/S1286-4579(01)01473-3
  136. Natarajan R; Thathy V; Mota MM; Hafalla JC; Ménard R; Vernick KD. "Fluorescent Plasmodium berghei sporozoites and pre-erythrocytic stages: a new tool to study mosquito and mammalian host interactions with malaria parasites.". (2001): http://europepmc.org/abstract/med/11422080.
    10.1046/j.1462-5822.2001.00117.x
  137. Mota MM; Brown KN; Do Rosário VE; Holder AA; Jarra W. "Antibody recognition of rodent malaria parasite antigens exposed at the infected erythrocyte surface: specificity of immunity generated in hyperimmune mice.". (2001): http://europepmc.org/abstract/med/11254617.
    10.1128/IAI.69.4.2535-2541.2001
  138. Mota MM; Thathy V; Nussenzweig RS; Nussenzweig V. "Gene targeting in the rodent malaria parasite Plasmodium yoelii.". (2001): http://europepmc.org/abstract/med/11295181.
    10.1016/S0166-6851(01)00228-6
  139. Matuschewski K; Mota MM; Pinder JC; Nussenzweig V; Kappe SH. "Identification of the class XIV myosins Pb-MyoA and Py-MyoA and expression in Plasmodium sporozoites.". (2001): http://europepmc.org/abstract/med/11166399.
    10.1016/S0166-6851(00)00360-1
  140. Mota, M.M.; Pradel, G.; Vanderberg, J.P.; Hafalla, J.C.R.; Frevert, U.; Nussenzweig, R.S.; Nussenzweig, V.; Rodriguez, A.. "Migration of Plasmodium sporozoites through cells before infection". Science 291 5501 (2001): 141-144. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035808562&partnerID=MN8TOARS.
    10.1126/science.291.5501.141
  141. Mota, M.M.; Rodríguez, A.. "Plasmodium invasion of mosquito cells: hawk or dove? Response from Mota and Rodríguez". Trends in Parasitology 17 5 (2001): http://www.scopus.com/inward/record.url?eid=2-s2.0-0035005943&partnerID=MN8TOARS.
  142. Mota MM; Rodriguez A. "Plasmodium yoelii: efficient in vitro invasion and complete development of sporozoites in mouse hepatic cell lines.". (2000): http://europepmc.org/abstract/med/11162379.
    10.1006/expr.2000.4570
  143. Mota, M.M.; Jarra, W.; Hirst, E.; Patnaik, P.K.; Holder, A.A.. "Plasmodium chabaudi-infected erythrocytes adhere to CD36 and bind to microvascular endothelial cells in an organ-specific way". Infection and Immunity 68 7 (2000): 4135-4144. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033918169&partnerID=MN8TOARS.
    10.1128/IAI.68.7.4135-4144.2000
  144. Mota, M.M.; Jarra, W.. "More on adaptive or innate resistance to Plasmodium [4]". Parasitology Today 15 5 (1999): http://www.scopus.com/inward/record.url?eid=2-s2.0-0032926201&partnerID=MN8TOARS.
  145. Mota, M.M.; Brown, K.N.; Holder, A.A.; Jarra, W.. "Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surfaces of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro". Infection and Immunity 66 9 (1998): 4080-4086. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031719250&partnerID=MN8TOARS.
Capítulo de livro
  1. Götz, A.; Ty, M.; Chora, A.F.; Zuzarte-Luís, V.; Mota, M.M.; Rodriguez, A.. "Innate immunity to malaria". 3-25. 2017.
Livro
  1. Mota, M.M.; Rodriguez, A.. Malaria: Immune response to infection and vaccination. 2017.
    10.1007/978-3-319-45210-4
  2. Sinnis, P.; De La Vega, P.; Coppi, A.; Krzych, U.; Mota, M.M.; Sinnis P; De La Vega P; et al. Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry. 2013.
    10.1007/978-1-62703-26-7_27
Atividades

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2018 - 2024/01/05 A Metabolic Arms Race Between Host and Parasite: Amino Acid Sensing and Response in Plasmodium
Coorientador
 Biologia Básica e Aplicada (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2017 - 2022/10/04 Microbiota: Understanding its role in the Host-Plasmodium affair
Orientador
 Ciências Biomédicas (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
2017/01/01 - 2021/07/30 Endosomal dynamics at the Host-Plasmodium interface through liver-stage parasite development
Orientador de Aparajita Lahree
Universidade de Lisboa Instituto Superior Técnico, Portugal
2015 - 2020 Uncovering the UIS4 protein interacting network and its role during the malaria liver stage infection.
Orientador de Viriato M'Bana
 Ciências Biomédicas (Parasitologia/Microbiologia) (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
2014 - 2015 Characterizing Iron transporters in Plasmodium species
Coorientador de Aparajita Lahree
Mestrado em Biologia Molecular e Celular (Mestrado)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
2008 - 2013 The Liver Endoplasmic Reticulum response in Malaria Liver infection
Orientador de Patrícia Inácio
 Doutoramento em Biologia (Biologia Celular) (Doutoramento)
Universidade Nova de Lisboa, Portugal
2008 - 2012 Probing the role of host lipids during hepatocyte infection by malaria parasite
Orientador de Maurice Itoe
 Doutoramento em Ciências Biomédicas (Ciências Biopatológicas) (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
2006 - 2010 Interactions of Plasmodium blood and liver stages within a single host
Orientador de Sílvia Portugal
Ciências Biomédicas (Ciências Biopatológicas) (Doutoramento)
Universidade de Lisboa Faculdade de Medicina, Portugal
2006 - 2010 Plasmodium fitness: The importance of being prepared. Plasmodium sporozoites post-transcriptional regulation of gene expression and host cell cytoskeleton dynamics during Plasmodium intra-hepatic development.
Orientador de Carina Gomes-Santos
Doutoramento em Biologia Celular
Universidade de Coimbra, Portugal
2007 - 2008 Plasmodium infection of mammalian host: effects of vitamin D
Orientador de Nuno Baltazar do Carmo
Mestrado em Microbiologia Clínica (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
2003 - 2007 The role of VEGF during a malaria infection
Orientador de Marta Campos
Doutoramento em Biologia (Biologia Molecular) (Doutoramento)
Universidade Nova de Lisboa, Portugal
2003 - 2007 Characterization of host cell response to Plasmodium infection: identification of hepatocyte genes involved in parasite development
Orientador de Sónia Albuquerque
Doutoramento em Ciências Biomédicas
Universidade do Porto, Portugal
2002 - 2007 Revealing host factors important for hepatocyte infection by Plasmodium
Orientador de Cristina Rodrigues
Doutoramento em Biologia (Biologia Celular) (Doutoramento)
Universidade de Lisboa Faculdade de Ciências, Portugal
2002 - 2007 Approaching host targets in murine malaria
Orientador de Margarida Cunha-Rodrigues
Doutoramento em Ciências Biomédicas
Universidade do Porto, Portugal
2002 - 2006 Plasmodium-Hepatocyte interactions: implications for protection against Malaria
Orientador de Patrícia Leirião
Doutoramento em Ciências Biomédicas (Parasitologia)
Universidade Nova de Lisboa, Portugal
2002 - 2006 Immunization with mutant Plasmodium parasites: how is that achieved?
Orientador de Bruno Douradinha
 Doutoramento em Ciências Biomédicas (Ciências Biopatológicas)
Universidade de Lisboa Faculdade de Medicina, Portugal

Organização de evento

Nome do evento
Tipo de evento (Tipo de participação) 		Instituição / Organização
2018/06/24 - 2018/06/27 EMBO|EMBL symposia. Innate Immunity in Host-Pathogen Interactions. Scientific Organizer. (2018/06/24 - 2018/06/27)
Simpósio (Membro da Comissão Organizadora)
2015/06 - 2015/06 Biology of Sporozoites and Liverstages, Gordon Research Conferences - Translating Malaria Research to the Field, Girona, Spain - Conference Vice-Chair, Session Discussion Leader (2015/06 - 2015/06)
Conferência (Outra)
2015/05 - 2015/05 11th Biomalpar /Evimalar Conference - Biology and Pathology of the Malaria Parasite, EMBL, Heidelberg, Germany - Scientific Organizer (2015/05 - 2015/05)
Conferência (Coorganizador)
2010 - 2010 Malarial Disease: Contribution of Host Response - at the Keystone Symposia “Malaria: New Approaches to Understanding Host-Parasite Interactions”, Colorado - Chair of the Scientific Session (2010 - 2010)
Simpósio (Outra)
2007 - 2007 Malaria at the 13th International Congress of Immunology. Rio de Janeiro, Brazil - Chair of the Scientific Session (2007 - 2007)
Congresso (Outra)

Arbitragem científica em revista

Nome da revista (ISSN) Editora
2010 - Atual Cellular Microbiology (1462-5822) Wiley (Blackwell Publishing)
2008 - Atual PLoS Pathogens (1553-7374) Public Library of Science
2007 - Atual International Journal for Parasitology (0020-7519) Elsevier

Membro de comissão

Descrição da atividade
Tipo de participação 		Instituição / Organização
2008 - Atual Ad hoc reviewer for ESF
2006 - Atual Ad hoc reviewer for MRC Fellowships - UK
2005 - Atual Ad hoc reviewer and evaluation panel for Wellcome Trust - UK
Outro
 Wellcome Trust, Reino Unido
2013 - 2015 Member of CNCT – National Council of Science and Technology (Board of Advisers to the Portuguese Government)
Membro
2010 - 2010 Evaluation panel of NIH International Centers of Excellence for Malaria Research
2005 - 2006 Evaluation panel life sciences / health sciences FP6 – EU
Distinções

Prémio

2019 Prémio Dona Antónia Adelaide Ferreira - Career Achievement Award
Porto Ferreira - Sogrape, Portugal
2018 Sanofi – Institut Pasteur International Mid-Career Award in microbiology & infection
2017 Pfizer Award in Basic Research
2013 Prémio Pessoa
2011 Prémio BES de Inovação
2009 Prémio Saúde
2009 Prémio Rotary Investigação-Ciência
Rotary Club, Portugal
2008 Prémio Amélia da Silva de Mello para as Ciências da Saúde
2007 Seeds of Science Award
Ciência Hoje, Portugal
2007 Prémio Internacional de Investigação CESPU
Cooperativa de Ensino Superior Politécnico e Universitário Escola Universitária de Bragança, Portugal
2004 European Young Investigator Award (EURYI)
European Science Foundation, França
2003 Young Investigator Award

Outra distinção

2016 EMBO Member
2005 Comendadora da Ordem do Infante D. Henrique
2005 Howard Hughes Scholar
Howard Hughes Medical Institute, Estados Unidos